US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

MTCR

Metacrine (MTCR)

Metacrine Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:MTCR

<< 前へ 1 2 3 4 5

日付	受信時刻	ニュースソース	見出し	コード	企業名
2021/03/11	20 : 30	GlobeNewswire Inc.	Metacrine to Present Final Results from Phase 1 Trial of MET642, an Optimized FXR Agonist, at the 2021 NASH-TAG Conference	NASDAQ:MTCR	Metacrine Inc
2021/03/11	20 : 15	GlobeNewswire Inc.	Metacrine Announces Date of Fourth Quarter and Full Year 2020 Financial Results Conference Call	NASDAQ:MTCR	Metacrine Inc
2021/03/09	20 : 30	GlobeNewswire Inc.	Metacrine Initiates Phase 2a Trial of MET642 for the Treatment of Patients with NASH	NASDAQ:MTCR	Metacrine Inc
2021/03/02	20 : 30	GlobeNewswire Inc.	Metacrine to Present at H.C. Wainwright 2021 Global Life Sciences Conference	NASDAQ:MTCR	Metacrine Inc
2021/02/19	20 : 30	GlobeNewswire Inc.	Metacrine to Present at SVB Leerink 10th Annual Global Healthcare Conference	NASDAQ:MTCR	Metacrine Inc
2021/02/17	07 : 10	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:MTCR	Metacrine Inc
2021/02/16	20 : 30	GlobeNewswire Inc.	Metacrine Announces Publication of MET409 NASH Proof-of-Concept Study Results in the Journal of Hepatology	NASDAQ:MTCR	Metacrine Inc
2021/02/16	20 : 17	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:MTCR	Metacrine Inc
2021/02/13	08 : 29	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:MTCR	Metacrine Inc
2021/02/13	07 : 44	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MTCR	Metacrine Inc
2021/02/13	07 : 39	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MTCR	Metacrine Inc
2021/02/13	07 : 32	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MTCR	Metacrine Inc
2021/02/03	07 : 05	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:MTCR	Metacrine Inc
2021/02/03	02 : 53	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:MTCR	Metacrine Inc
2021/01/19	20 : 30	GlobeNewswire Inc.	Metacrine Announces FDA Fast Track Designation for MET642 as a Treatment of NASH	NASDAQ:MTCR	Metacrine Inc
2021/01/05	20 : 30	GlobeNewswire Inc.	Metacrine Initiates Phase 2a Combination Trial of MET409 with Empagliflozin in Patients with Type 2 Diabetes and NASH	NASDAQ:MTCR	Metacrine Inc
2020/12/17	20 : 30	GlobeNewswire Inc.	Metacrine Reports Positive Results from Phase 1 Trial of MET642	NASDAQ:MTCR	Metacrine Inc
2020/11/23	20 : 30	GlobeNewswire Inc.	Metacrine to Participate in Upcoming Investor Conferences	NASDAQ:MTCR	Metacrine Inc
2020/11/12	20 : 43	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:MTCR	Metacrine Inc
2020/11/12	20 : 36	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MTCR	Metacrine Inc
2020/11/12	20 : 30	GlobeNewswire Inc.	Metacrine Reports Business Updates and Third Quarter 2020 Financial Results	NASDAQ:MTCR	Metacrine Inc
2020/11/10	08 : 46	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:MTCR	Metacrine Inc
2020/10/02	05 : 01	GlobeNewswire Inc.	Metacrine to Present New Data from MET409 Program in NASH at AASLD’s The Liver Meeting Digital Experience™	NASDAQ:MTCR	Metacrine Inc
2020/09/30	05 : 07	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:MTCR	Metacrine Inc
2020/09/29	03 : 19	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:MTCR	Metacrine Inc
2020/09/24	05 : 59	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:MTCR	Metacrine Inc
2020/09/16	10 : 52	GlobeNewswire Inc.	Metacrine Announces Pricing of Initial Public Offering	NASDAQ:MTCR	Metacrine Inc

Showing the most relevant articles for your search:NASDAQ:MTCR

<< 前へ 1 2 3 4 5

Energy Select Sector SPDR

Gold vs US Dollar

Verizon Communications

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約